PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 134 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.37 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $40,770 | +106.7% | 16,051 | +52.1% | 0.00% | – |
| Q4 2022 | $19,729 | -63.5% | 10,550 | -42.1% | 0.00% | – |
| Q1 2022 | $54,000 | -31.6% | 18,211 | +4.4% | 0.00% | – |
| Q4 2021 | $79,000 | -12.2% | 17,446 | -5.6% | 0.00% | – |
| Q3 2021 | $90,000 | -9.1% | 18,484 | +27.2% | 0.00% | – |
| Q2 2021 | $99,000 | -87.2% | 14,534 | -89.8% | 0.00% | – |
| Q3 2020 | $771,000 | -79.9% | 142,486 | -6.7% | 0.00% | -100.0% |
| Q3 2017 | $3,834,000 | -53.8% | 152,754 | -55.6% | 0.00% | -66.7% |
| Q2 2017 | $8,300,000 | +22955.6% | 344,399 | +24239.2% | 0.00% | – |
| Q2 2015 | $36,000 | – | 1,415 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,600,410 | $36,172,000 | 26.83% |
| Abingworth LLP | 1,301,413 | $18,103,000 | 18.96% |
| Roumell Asset Management, LLC | 290,136 | $4,036,000 | 9.16% |
| Monashee Investment Management LLC | 100,000 | $1,391,000 | 2.19% |
| BVF INC/IL | 575,000 | $7,998,000 | 1.70% |
| Aisling Capital LLC | 482,680 | $6,714,000 | 1.59% |
| Opaleye Management Inc. | 146,700 | $2,041,000 | 1.36% |
| Broadfin Capital, LLC | 803,332 | $11,174,000 | 1.09% |
| GENERAL AMERICAN INVESTORS CO INC | 477,076 | $6,636,000 | 0.69% |
| Opus Point Partners Management, LLC | 37,665 | $524,000 | 0.51% |